[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Biotechnology in Brazil

June 2020 | 42 pages | ID: BFB065052B1EN
MarketLine

US$ 350.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Biotechnology in Brazil

SUMMARY

Biotechnology in Brazil industry profile provides top-line qualitative and quantitative summary information including: market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY HIGHLIGHTS
  • The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
  • The Brazilian biotechnology market had total revenues of $17.5bn in 2019, representing a compound annual growth rate (CAGR) of 4.9% between 2015 and 2019.
  • The medical/healthcare segment was the market's most lucrative in 2019, with total revenues of $9.4bn, equivalent to 54% of the market's overall value.
  • Compared with pharmas, biotech companies will have more difficulty compensating for supply chain disruptions from COVID-19, due to the high costs associated with their RandD.
SCOPE
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Brazil
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Brazil
  • Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Brazil biotechnology market with five year forecasts
REASONS TO BUY
  • What was the size of the Brazil biotechnology market by value in 2019?
  • What will be the size of the Brazil biotechnology market in 2024?
  • What factors are affecting the strength of competition in the Brazil biotechnology market?
  • How has the market performed over the last five years?
  • What are the main segments that make up Brazil's biotechnology market?
1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Category segmentation
4.2. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Who are the leading players?
7.2. What strategies do the leading players follow?
7.3. What are the strengths of leading players?
7.4. Have been any notable strategic partnerships in recent years?
7.5. What opportunities are there for leading players?
7.6. How might COVID-19 affect the competitive landscape?

8 COMPANY PROFILES

8.1. Braskem SA
8.2. EMS SA
8.3. Suzano SA
8.4. Sanofi SA

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

LIST OF TABLES

Table 1: Brazil biotechnology industry value: $ billion, 2015-19
Table 2: Brazil biotechnology industry category segmentation: $ billion, 2019
Table 3: Brazil biotechnology industry geography segmentation: $ billion, 2019
Table 4: Brazil biotechnology industry value forecast: $ billion, 2019-24
Table 5: Braskem SA: key facts
Table 6: Braskem SA: Annual Financial Ratios
Table 7: Braskem SA: Annual Financial Ratios (Continued)
Table 8: Braskem SA: Key Employees
Table 9: EMS SA: key facts
Table 10: EMS SA: Key Employees
Table 11: Suzano SA: key facts
Table 12: Suzano SA: Annual Financial Ratios
Table 13: Suzano SA: Annual Financial Ratios (Continued)
Table 14: Suzano SA: Key Employees
Table 15: Sanofi SA: key facts
Table 16: Sanofi SA: Annual Financial Ratios
Table 17: Sanofi SA: Key Employees
Table 18: Sanofi SA: Key Employees Continued
Table 19: Brazil size of population (million), 2015-19
Table 20: Brazil gdp (constant 2005 prices, $ billion), 2015-19
Table 21: Brazil gdp (current prices, $ billion), 2015-19
Table 22: Brazil inflation, 2015-19
Table 23: Brazil consumer price index (absolute), 2015-19
Table 24: Brazil exchange rate, 2015-19

LIST OF FIGURES

Figure 1: Brazil biotechnology industry value: $ billion, 2015-19
Figure 2: Brazil biotechnology industry category segmentation: % share, by value, 2019
Figure 3: Brazil biotechnology industry geography segmentation: % share, by value, 2019
Figure 4: Brazil biotechnology industry value forecast: $ billion, 2019-24
Figure 5: Forces driving competition in the biotechnology industry in Brazil, 2019
Figure 6: Drivers of buyer power in the biotechnology industry in Brazil, 2019
Figure 7: Drivers of supplier power in the biotechnology industry in Brazil, 2019
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Brazil, 2019
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Brazil, 2019
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Brazil, 2019


More Publications